Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities

Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities

There are no FDA-approved drugs to mitigate the delayed effects of radiation exposure that may occur after a radiological attack or nuclear accident. To date, angiotensin-converting enzyme inhibitors are one of the most successful candidates for mitigation of hematopoietic, lung, kidney, and brain i...

Full description

Saved in:
Bibliographic Details
Main Authors: Meetha Medhora (Author), Preeya Phadnis (Author), Jayashree Narayanan (Author), Tracy Gasperetti (Author), Jacek Zielonka (Author), John E. Moulder (Author), Brian L. Fish (Author), Aniko Szabo (Author)
Format: Book
Published: Frontiers Media S.A., 2021-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items